Patient-derived cancer cell lines could address two major challenges in oncology: real-time drug response prediction and the creation of massive knowledge banks. A new study showcases the power of this approach for precision oncology.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A recursive framework for predicting the time-course of drug sensitivity
Scientific Reports Open Access 19 October 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hutter, C. & Zenklusen, J. C. Cell 173, 283–285 (2018).
Sanchez-Vega, F. et al. Cell 173, 321–337 (2018).
Iorio, F. et al. Cell 166, 740–754 (2016).
Lee, J.-K. et al. Nat. Genet. https://doi.org/10.1038/s41588-018-0209-6 (2018).
van de Wetering, M. et al. Cell 161, 933–945 (2015).
Vlachogiannis, G. et al. Science 359, 920–926 (2018).
Lee, S. H. et al. Cell 173, 515–528 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
McDermott, U. Cancer cell lines as patient avatars for drug response prediction. Nat Genet 50, 1350–1351 (2018). https://doi.org/10.1038/s41588-018-0245-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0245-2
